Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Urologia Internationalis|February 10, 2015
Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladderJairam R Eswara, Niall M Heney, Chin-Lee Wu, et al.BJU International|November 28, 2008
Bladder preservation: optimizing radiotherapy and integrated treatment strategiesRaymond H Mak, Anthony L Zietman, Niall M Heney, et al.World Journal of Urology|November 4, 2006
Bladder-sparing approaches to invasive diseaseJason A Efstathiou, Anthony L Zietman, Donald S Kaufman, et al.Current Urology Reports|January 24, 2013
Trimodality therapy for bladder conservation in treatment of invasive bladder cancerTimur Mitin, William U Shipley, Jason A Efstathiou, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06Jason A Efstathiou, Kyounghwa Bae, William U Shipley, et al.BJU International|January 22, 2009
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?Jennifer Y Wo, William U Shipley, Douglas M Dahl, et al.The Journal of Urology|December 20, 2011
Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancerJairam R Eswara, Jason A Efstathiou, Niall M Heney, et al.Urology|December 23, 2008
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapyDonald S Kaufman, Kathryn A Winter, William U Shipley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233Raymond H Mak, Daniel Hunt, William U Shipley, et al.International Journal of Radiation Oncology, Biology, Physics|March 12, 2013
Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancerJohn J Coen, Jonathan J Paly, Andrzej Niemierko, et al.Pageof 2